Inventor · disambiguated record
Malini Viswanathan
Also filed as: VISWANATHAN MALINI
21 granted patents·19 pending applications·205 citations·filing 2011–2024
95Inventor score
Files withDYAX CORP19TAKEDA PHARMACEUTICALS CO13SEXTON DANIEL J3PHOENIX TISSUE REPAIR INC2SYNTONIX PHARMACEUTICALS INC1
Top patents by PatentIndex Score
40 records- 0197US10370453B2Plasma kallikrein binding proteinsDYAX CORP·Filed 2015·Granted Aug 6, 2019·25 cites·9 claims
- 0296US11505620B2Methods of detecting plasma kallikreinTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Nov 22, 2022·6 cites·20 claims
- 0396US8822653B2Plasma kallikrein binding proteinsSEXTON DANIEL J·Filed 2011·Granted Sep 2, 2014·27 cites·32 claims
- 0495US9266964B2Method of treating hereditary angioedema using plasma kallikrein binding antibodiesDYAX CORP·Filed 2014·Granted Feb 23, 2016·24 cites·6 claims
- 0595US9260520B2Antibodies to FeRn and uses thereofDYAX CORP·Filed 2014·Granted Feb 16, 2016·18 cites·6 claims
- 0695US8816055B2Plasma kallikrein binding proteinsSEXTON DANIEL J·Filed 2012·Granted Aug 26, 2014·29 cites·7 claims
- 0794US8815246B2Fc receptor binding proteinsTENHOOR CHRISTOPHER·Filed 2012·Granted Aug 26, 2014·18 cites·12 claims
- 0893US11340237B2Metabolite biomarkers for diseases associated with the contact activation systemTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted May 24, 2022·7 cites·26 claims
- 0993US10336832B2Methods of inhibiting plasma kallikrein in edema patientDYAX CORP·Filed 2014·Granted Jul 2, 2019·13 cites·7 claims
- 1091US9862768B2Methods of producing antibodies to neonatal Fc receptor (FcRn)DYAX CORP·Filed 2016·Granted Jan 9, 2018·7 cites·12 claims
- 1189US11739152B2Antibodies which bind Fc receptors (FcRn)TAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 29, 2023·1 cites·16 claims
- 1289US11401346B2Nucleic acids encoding plasma kallikrein binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 2, 2022·5 cites·21 claims
- 1389US11014988B2Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodiesDYAX CORP·Filed 2019·Granted May 25, 2021·2 cites·19 claims
- 1488US10479834B2Fc receptor antibodies and methods of use thereofDYAX CORP·Filed 2017·Granted Nov 19, 2019·4 cites·16 claims
- 1588US9359438B2Human neonatal Fc receptor antibodies and methods of use thereofSEXTON DANIEL J·Filed 2012·Granted Jun 7, 2016·9 cites·17 claims
- 1687US12454575B2Nucleic acids encoding FcRn-binding antibodies, pharmaceutical compositions thereof and methods of use thereof to make antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Oct 28, 2025·0 cites·22 claims
- 1785US12460016B2Plasma kallikrein binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Nov 4, 2025·0 cites·8 claims
- 1884US2025199014A1Metabolite biomarkers for diseases associated with the contact activation systemTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1982US9676837B2Collagen 7 and related methodsVISWANATHAN MALINI·Filed 2012·Granted Jun 13, 2017·10 cites·15 claims
- 2080US2023112931A1Plasma kallikrein binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2177US12188948B2Metabolite biomarkers for diseases associated with the contact activation systemTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 7, 2025·0 cites·18 claims
- 2277US2024142468A1Protein biomarkers for diseases associated with the contact activation systemTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2375US2024271211A1Rna biomarkers for hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2467US2018002447A1Plasma kallikrein binding proteinsDYAX CORP·Filed 2017·Application pending·0 cites
- 2567US2018037665A1Plasma kallikrein binding proteinsDYAX CORP·Filed 2017·Application pending·0 cites
- 2667US2018002449A1Plasma kallikrein binding proteinsDYAX CORP·Filed 2017·Application pending·0 cites
- 2767US2018002448A1Plasma kallikrein binding proteinsDYAX CORP·Filed 2017·Application pending·0 cites
- 2867US2018037666A1Plasma kallikrein binding proteinsDYAX CORP·Filed 2017·Application pending·0 cites
- 2967US2018037664A1Plasma kallikrein binding proteinsDYAX CORP·Filed 2017·Application pending·0 cites
- 3065US2016222110A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3165US2013045218A1Fc receptor binding proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3263US2016194397A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3363US2016222111A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3463US2016222112A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3563US2016222109A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3663US2016222108A1Fc receptor binding proteinsDYAX CORP·Filed 2015·Application pending·0 cites
- 3762US11884979B2RNA biomarkers for hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jan 30, 2024·0 cites·26 claims
- 3862US11815516B2Protein biomarkers for diseases associated with the contact activation systemTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Nov 14, 2023·0 cites·18 claims
- 3943US2022177546A1Systems and methods for producing collagen 7 compositionsPHOENIX TISSUE REPAIR INC·Filed 2020·Application pending·0 cites
- 4030US2018002401A1Collagen 7 and related methodsPHOENIX TISSUE REPAIR INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →